Beneficial effect of moderate white wine consumption on insulin sensitivity in patients with metabolic syndrome

T. Ábel, A. Blázovics, A. Wimmer, G. Bekő, B. Gaál, B. Blazics, M. Eldin, J. Fehér, I. Szabolcs, G. Lengyel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effect of moderate alcohol consumption on insulin sensitivity is actually a topic of intense research nowadays. In this study we investigated the effect of moderate consumption of white wine in subjects with metabolic syndrome. Thirty-two patients with metabolic syndrome participated in this prospective, randomised, double-blind study. The subjects received either Müller-Thurgau (n=14) or Pintes (n=18) sort of wine for 4 weeks. Male and female subjects consumed 300 ml wine (30 g alcohol) and 200 ml wine (20 g alcohol) per day, respectively. Clinical and laboratory parameters were determined before and after the period of wine consumption. The HOMA-IR showed a significant decrease upon the consumption of both sorts of wine as compared to the baseline (Müller-Thurgau group: 1.85±2.1 vs. 1.06±0.6; P=0.03; Pintes group: 2.28±2.04 vs. 1.08±0.6; P=0.002). Four weeks of wine consumption lead to significant decreased of ALT (alanine aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.002) and AST (aspartate aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.02). Epidermal growth factor (EGF) levels increased significantly in both groups (Müller-Thurgau group: P=0.004; Pintes group: P=0.001). The plasma reducing capacity increased significantly upon the consumption of both sorts of wine (Müller-Thurgau group: P=0.002; Pintes group: P=0.001). In patients consuming Müller-Thurgau there was a significant decrease of total cholesterol (5.4±1.4 vs. 4.9±1.2 mmol l-1; P=0.006) and LDL-cholesterol (3.9±1.1 vs. 3.6±1.2 mmol l-1; P=0.04) levels. In the Pintes group we found no significant difference either in total cholesterol (5.1±0.6 vs. 5.0±0.7 mmol l-1; P=0.25) or LDL-cholesterol (3.6±0.6 vs. 3.6±0.6 mmol l-1; P=0.5) concentrations. The results of our study confirm that moderate consumption of white wine increases insulin sensitivity and EGF levels in persons with metabolic syndrome.

Original languageEnglish
Pages (from-to)631-639
Number of pages9
JournalActa Alimentaria
Volume42
Issue number4
DOIs
Publication statusPublished - Dec 1 2013

Fingerprint

white wines
metabolic syndrome
Wine
insulin resistance
Insulin Resistance
wines
epidermal growth factor
low density lipoprotein cholesterol
alcohols
Epidermal Growth Factor
cholesterol
LDL Cholesterol
Cholesterol
Alcohols
alanine transaminase
aspartate transaminase
Aspartate Aminotransferases
Alanine Transaminase
Double-Blind Method
Alcohol Drinking

Keywords

  • cholesterol
  • CRP
  • EGF
  • HOMA-IR
  • insulin

ASJC Scopus subject areas

  • Food Science

Cite this

Beneficial effect of moderate white wine consumption on insulin sensitivity in patients with metabolic syndrome. / Ábel, T.; Blázovics, A.; Wimmer, A.; Bekő, G.; Gaál, B.; Blazics, B.; Eldin, M.; Fehér, J.; Szabolcs, I.; Lengyel, G.

In: Acta Alimentaria, Vol. 42, No. 4, 01.12.2013, p. 631-639.

Research output: Contribution to journalArticle

@article{89eed15611914ba69139b94bf6d0f202,
title = "Beneficial effect of moderate white wine consumption on insulin sensitivity in patients with metabolic syndrome",
abstract = "The effect of moderate alcohol consumption on insulin sensitivity is actually a topic of intense research nowadays. In this study we investigated the effect of moderate consumption of white wine in subjects with metabolic syndrome. Thirty-two patients with metabolic syndrome participated in this prospective, randomised, double-blind study. The subjects received either M{\"u}ller-Thurgau (n=14) or Pintes (n=18) sort of wine for 4 weeks. Male and female subjects consumed 300 ml wine (30 g alcohol) and 200 ml wine (20 g alcohol) per day, respectively. Clinical and laboratory parameters were determined before and after the period of wine consumption. The HOMA-IR showed a significant decrease upon the consumption of both sorts of wine as compared to the baseline (M{\"u}ller-Thurgau group: 1.85±2.1 vs. 1.06±0.6; P=0.03; Pintes group: 2.28±2.04 vs. 1.08±0.6; P=0.002). Four weeks of wine consumption lead to significant decreased of ALT (alanine aminotransferase; M{\"u}ller-Thurgau group: P=0.003; Pintes group: P=0.002) and AST (aspartate aminotransferase; M{\"u}ller-Thurgau group: P=0.003; Pintes group: P=0.02). Epidermal growth factor (EGF) levels increased significantly in both groups (M{\"u}ller-Thurgau group: P=0.004; Pintes group: P=0.001). The plasma reducing capacity increased significantly upon the consumption of both sorts of wine (M{\"u}ller-Thurgau group: P=0.002; Pintes group: P=0.001). In patients consuming M{\"u}ller-Thurgau there was a significant decrease of total cholesterol (5.4±1.4 vs. 4.9±1.2 mmol l-1; P=0.006) and LDL-cholesterol (3.9±1.1 vs. 3.6±1.2 mmol l-1; P=0.04) levels. In the Pintes group we found no significant difference either in total cholesterol (5.1±0.6 vs. 5.0±0.7 mmol l-1; P=0.25) or LDL-cholesterol (3.6±0.6 vs. 3.6±0.6 mmol l-1; P=0.5) concentrations. The results of our study confirm that moderate consumption of white wine increases insulin sensitivity and EGF levels in persons with metabolic syndrome.",
keywords = "cholesterol, CRP, EGF, HOMA-IR, insulin",
author = "T. {\'A}bel and A. Bl{\'a}zovics and A. Wimmer and G. Bekő and B. Ga{\'a}l and B. Blazics and M. Eldin and J. Feh{\'e}r and I. Szabolcs and G. Lengyel",
year = "2013",
month = "12",
day = "1",
doi = "10.1556/AAlim.2013.1111",
language = "English",
volume = "42",
pages = "631--639",
journal = "Acta Alimentaria",
issn = "0139-3006",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - Beneficial effect of moderate white wine consumption on insulin sensitivity in patients with metabolic syndrome

AU - Ábel, T.

AU - Blázovics, A.

AU - Wimmer, A.

AU - Bekő, G.

AU - Gaál, B.

AU - Blazics, B.

AU - Eldin, M.

AU - Fehér, J.

AU - Szabolcs, I.

AU - Lengyel, G.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - The effect of moderate alcohol consumption on insulin sensitivity is actually a topic of intense research nowadays. In this study we investigated the effect of moderate consumption of white wine in subjects with metabolic syndrome. Thirty-two patients with metabolic syndrome participated in this prospective, randomised, double-blind study. The subjects received either Müller-Thurgau (n=14) or Pintes (n=18) sort of wine for 4 weeks. Male and female subjects consumed 300 ml wine (30 g alcohol) and 200 ml wine (20 g alcohol) per day, respectively. Clinical and laboratory parameters were determined before and after the period of wine consumption. The HOMA-IR showed a significant decrease upon the consumption of both sorts of wine as compared to the baseline (Müller-Thurgau group: 1.85±2.1 vs. 1.06±0.6; P=0.03; Pintes group: 2.28±2.04 vs. 1.08±0.6; P=0.002). Four weeks of wine consumption lead to significant decreased of ALT (alanine aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.002) and AST (aspartate aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.02). Epidermal growth factor (EGF) levels increased significantly in both groups (Müller-Thurgau group: P=0.004; Pintes group: P=0.001). The plasma reducing capacity increased significantly upon the consumption of both sorts of wine (Müller-Thurgau group: P=0.002; Pintes group: P=0.001). In patients consuming Müller-Thurgau there was a significant decrease of total cholesterol (5.4±1.4 vs. 4.9±1.2 mmol l-1; P=0.006) and LDL-cholesterol (3.9±1.1 vs. 3.6±1.2 mmol l-1; P=0.04) levels. In the Pintes group we found no significant difference either in total cholesterol (5.1±0.6 vs. 5.0±0.7 mmol l-1; P=0.25) or LDL-cholesterol (3.6±0.6 vs. 3.6±0.6 mmol l-1; P=0.5) concentrations. The results of our study confirm that moderate consumption of white wine increases insulin sensitivity and EGF levels in persons with metabolic syndrome.

AB - The effect of moderate alcohol consumption on insulin sensitivity is actually a topic of intense research nowadays. In this study we investigated the effect of moderate consumption of white wine in subjects with metabolic syndrome. Thirty-two patients with metabolic syndrome participated in this prospective, randomised, double-blind study. The subjects received either Müller-Thurgau (n=14) or Pintes (n=18) sort of wine for 4 weeks. Male and female subjects consumed 300 ml wine (30 g alcohol) and 200 ml wine (20 g alcohol) per day, respectively. Clinical and laboratory parameters were determined before and after the period of wine consumption. The HOMA-IR showed a significant decrease upon the consumption of both sorts of wine as compared to the baseline (Müller-Thurgau group: 1.85±2.1 vs. 1.06±0.6; P=0.03; Pintes group: 2.28±2.04 vs. 1.08±0.6; P=0.002). Four weeks of wine consumption lead to significant decreased of ALT (alanine aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.002) and AST (aspartate aminotransferase; Müller-Thurgau group: P=0.003; Pintes group: P=0.02). Epidermal growth factor (EGF) levels increased significantly in both groups (Müller-Thurgau group: P=0.004; Pintes group: P=0.001). The plasma reducing capacity increased significantly upon the consumption of both sorts of wine (Müller-Thurgau group: P=0.002; Pintes group: P=0.001). In patients consuming Müller-Thurgau there was a significant decrease of total cholesterol (5.4±1.4 vs. 4.9±1.2 mmol l-1; P=0.006) and LDL-cholesterol (3.9±1.1 vs. 3.6±1.2 mmol l-1; P=0.04) levels. In the Pintes group we found no significant difference either in total cholesterol (5.1±0.6 vs. 5.0±0.7 mmol l-1; P=0.25) or LDL-cholesterol (3.6±0.6 vs. 3.6±0.6 mmol l-1; P=0.5) concentrations. The results of our study confirm that moderate consumption of white wine increases insulin sensitivity and EGF levels in persons with metabolic syndrome.

KW - cholesterol

KW - CRP

KW - EGF

KW - HOMA-IR

KW - insulin

UR - http://www.scopus.com/inward/record.url?scp=84889837743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889837743&partnerID=8YFLogxK

U2 - 10.1556/AAlim.2013.1111

DO - 10.1556/AAlim.2013.1111

M3 - Article

VL - 42

SP - 631

EP - 639

JO - Acta Alimentaria

JF - Acta Alimentaria

SN - 0139-3006

IS - 4

ER -